Brainstorm Cell Therapeutics Inc.
BCLI
$0.69
$0.00-0.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 480.00% | -99.39% | -49.88% | 779.14% | 11.31% |
| Total Receivables | 7.50% | -24.53% | 58.21% | 6.35% | 57.50% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -54.61% | -27.69% | -5.80% | 360.00% | -13.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -39.57% | -66.47% | -35.03% | 505.71% | 5.77% |
|
|
|||||
| Total Current Assets | -39.57% | -66.47% | -35.03% | 505.71% | 5.77% |
| Net Property, Plant & Equipment | -28.20% | -25.30% | -20.19% | -16.60% | -14.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.67% | 13.33% | 10.29% | -0.97% | 1.48% |
| Total Assets | -25.94% | -46.22% | -28.14% | 94.92% | -9.53% |
|
|
|||||
| Total Accounts Payable | 10.08% | 7.05% | -11.77% | 11.79% | 32.09% |
| Total Accrued Expenses | 13.14% | -4.63% | -31.78% | -13.09% | -28.44% |
| Short-term Debt | 857.43% | 0.00% | -91.58% | 300.00% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.64% | -27.56% | -14.00% | -19.31% | -3.68% |
| Total Finance Division Other Current Liabilities | 26.28% | 11.53% | -12.53% | 34.48% | 36.97% |
| Total Other Current Liabilities | 26.28% | 11.53% | -12.53% | 34.48% | 36.97% |
| Total Current Liabilities | 21.99% | 5.80% | -21.77% | 21.42% | 26.77% |
|
|
|||||
| Total Current Liabilities | 21.99% | 5.80% | -21.77% | 21.42% | 26.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 857.43% | 0.00% | -91.58% | 300.00% | -- |
| Capital Leases | -- | -47.37% | -25.20% | -25.73% | -36.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -38.68% |
| Total Liabilities | 21.32% | 5.22% | -21.81% | 14.92% | 18.73% |
|
|
|||||
| Common Stock & APIC | 0.06% | 0.21% | 1.94% | 1.45% | 0.58% |
| Retained Earnings | -1.04% | -0.91% | -1.26% | -1.26% | -1.33% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -29.79% | -27.01% | 18.77% | 3.95% | -28.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.79% | -27.01% | 18.77% | 3.95% | -28.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.79% | -27.01% | 18.77% | 3.95% | -28.18% |
|
|
|||||